PUBLIC CONTRACT · 2021
Fremanezumab 225 mg/1.5 ml sol inj caneta 1.5 ml sc
- Contract value
- €57,348.61
- Signed on
- 7 April 2021
- Procedure
- Direct award, general (Ajuste Direto Regime Geral)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 7665441PUBLISHED SUBJECT
FREMANEZUMAB 225 MG/1.5 ML SOL INJ CANETA 1.5 ML SC
WHO CONTRACTED
Parties involved
- Place of performance
- Portugal, Região Autónoma da Madeira
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- TEVA PHARMA - PRODUTOS FARMACÊUTICOS, LDA. · Tax ID 507045491
HOW MUCH AND WHEN
Values and timeline
- Contract price
- €57,348.61
- Procedure base price
- €57,348.61
- Total effective price
- €1,924.45
- Publication date
- 18 May 2021
- Award date
- 6 April 2021
- Signing date
- 7 April 2021
- Performance period
- 268 days
The contract price is the value agreed in the contract, not the amount paid.
HOW IT WAS CONTRACTED
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Direct award, general (Ajuste Direto Regime Geral)
- Award criterion
- Melhor relação qualidade – preço
- CPV code
- 33690000-3 - Medicamentos vários
- Legal basis
- Artigo 24.º, n.º 1, alínea e), subalínea iii) do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL 111-B/2017 ) e DLR no 34/2008/M, de 14.08 (DLR n.º 6/2018/M)
- Framework agreement
- Not stated
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 5281373
KEEP EXPLORING
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.